Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL. 18. Juli 2018 Boegemann, M., Bedke, J., Schostak, M., Welslau, M., Hering-Schubert, T., Wolf, T., Schleicher, J., Ehness, R., Klein, D., Medinger, T., Goebell, P., 2018. Oncol Res Treat 41 (suppl4)(P602), 201-202. 705 patients with metastatic breast cancer treated with nab-paclitaxel: Results of the non-interventional study NABUCCO. Potthoff, K., Nusch, A., Söling, U., Hansen, R., Salat, C., Grebhardt, S., Harde, J., Marschner, N. 2018. Weiterlesen Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study). Wehmeyer, J., Zaiss, M., Losem, C., Schmitz, S., Niemeier, B., Harde, J., Hannig, C.V., Harich, H.-D., Müller, J., Klausmann, M., Tessen, H.W., Potthoff, K., 2018. Weiterlesen